| __timestamp | Sarepta Therapeutics, Inc. | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 94231000 | 2395000 |
| Thursday, January 1, 2015 | 146394000 | 9057000 |
| Friday, January 1, 2016 | 188272000 | 40818000 |
| Sunday, January 1, 2017 | 166707000 | 79309000 |
| Monday, January 1, 2018 | 401843000 | 134428000 |
| Tuesday, January 1, 2019 | 560909000 | 175431000 |
| Wednesday, January 1, 2020 | 722343000 | 130944000 |
| Friday, January 1, 2021 | 771182000 | 121875000 |
| Saturday, January 1, 2022 | 877090000 | 115856000 |
| Sunday, January 1, 2023 | 877387000 | 130009000 |
In pursuit of knowledge
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Sarepta Therapeutics, Inc. and Wave Life Sciences Ltd. have been at the forefront of this race. Since 2014, Sarepta has consistently outpaced Wave Life Sciences in R&D investment, with a staggering 830% increase by 2023. In contrast, Wave Life Sciences has seen a more modest growth of approximately 540% over the same period.
Sarepta's aggressive R&D strategy, peaking at nearly $880 million in 2023, underscores its dedication to advancing genetic medicine. Meanwhile, Wave Life Sciences, with its peak spending of around $175 million in 2019, continues to focus on precision medicine. This financial commitment highlights the dynamic landscape of biotech innovation, where strategic R&D investments can shape the future of healthcare.
Comparing Innovation Spending: Sanofi and Sarepta Therapeutics, Inc.
R&D Insights: How Zoetis Inc. and Sarepta Therapeutics, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Genmab A/S and Wave Life Sciences Ltd.
R&D Insights: How Insmed Incorporated and Wave Life Sciences Ltd. Allocate Funds
Analyzing R&D Budgets: BioMarin Pharmaceutical Inc. vs Wave Life Sciences Ltd.
R&D Spending Showdown: Sarepta Therapeutics, Inc. vs Axsome Therapeutics, Inc.
Sarepta Therapeutics, Inc. vs Ultragenyx Pharmaceutical Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs CymaBay Therapeutics, Inc.
Ascendis Pharma A/S vs Wave Life Sciences Ltd.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: PTC Therapeutics, Inc. vs Wave Life Sciences Ltd.
Research and Development: Comparing Key Metrics for Xenon Pharmaceuticals Inc. and Wave Life Sciences Ltd.
R&D Insights: How Agios Pharmaceuticals, Inc. and Wave Life Sciences Ltd. Allocate Funds